How are weight-loss injections regulated in the UK?

Which regulators actually oversee these medicines, and what do they each control?

Two separate bodies share oversight, and confusing their roles is surprisingly common. The MHRA (Medicines and Healthcare products Regulatory Agency) decides whether a medicine may be sold in the UK at all. It reviews the clinical evidence, grants a marketing authorisation, sets the legal classification (in this case, Prescription-Only), and issues safety communications when new risks emerge. Neither Mounjaro nor Wegovy would be on a UK pharmacy shelf without the MHRA's authorisation.

The GPhC (General Pharmaceutical Council) operates on a different plane. It registers and inspects the pharmacies (including online ones) that dispense those licensed medicines. A GPhC registration number is not a marketing badge; it is a legal requirement to operate as a pharmacy. You can check any pharmacy's registration directly at the GPhC's public register. If a seller dispensing these medicines does not appear there, it is operating outside the law.

Below those two sits NICE, which assesses whether a medicine is cost-effective for NHS use and produces clinical guidance. NICE recommended tirzepatide in technology appraisal TA1026, published December 2024, and recommended semaglutide (Wegovy) in TA875. NICE guidance shapes NHS access, but it does not restrict private prescribing, a licensed medicine can be prescribed privately without a NICE recommendation, provided a prescriber judges it clinically appropriate.

Then there is the prescriber themselves. UK law requires the prescriber to be registered with a relevant professional body, a doctor with the GMC, or a pharmacist or nurse prescriber with the GPhC or NMC. At nume (at nume) every consultation is read and decided by a GPhC-registered Independent Prescriber. A real clinician, not software, reviews your answers before anything is approved.

What does 'Prescription-Only' mean in practice for someone buying online?

The Prescription-Only classification, set out in the Human Medicines Regulations 2012, has practical teeth. A POM cannot be legally supplied unless a prescriber has assessed the patient and issued a valid prescription. That rules out vending machines, social-media sellers, and websites that ask you to tick a box and pay. It also rules out dispensing without identity checks, you need to be who you say you are, which is why legitimate services verify your photo ID and, in some cases, your current weight on a video call.

The POM classification interacts with advertising law too. The MHRA prohibits advertising Prescription-Only Medicines directly to the public. You will not see legitimate providers running discount codes or flash-sale promotions on Mounjaro or Wegovy. If a seller is doing that, it is a red flag worth taking seriously, what to look for in a legitimate provider covers the key checks in more detail.

There is one more dimension that often surprises people: the supply chain itself is regulated. Licensed UK pharmacies source medicines through MHRA-approved channels linked to the manufacturers, Eli Lilly for Mounjaro and Novo Nordisk for Wegovy. Counterfeits bypass that chain entirely, which is why the MHRA's enforcement teams have been active. Large seizures of fake pens have been made in recent years, some containing insulin rather than the stated medicine. Report any suspect seller via the MHRA's Yellow Card scheme.

Does the regulation differ for NHS versus private prescriptions?

The medicines themselves are regulated identically, an MHRA-authorised Mounjaro pen is the same product regardless of whether the prescription is NHS or private. What differs is the access pathway and the cost context.

On the NHS, NICE technology appraisals set the clinical criteria. Tirzepatide is currently being rolled out in phased cohorts, and NHS eligibility is stricter than the licensed indication. If you are curious about how the private route compares on cost, the weight-loss overview page lays out the landscape honestly without printing specific per-pen prices.

Privately, a prescriber can lawfully prescribe any licensed medicine that they judge clinically appropriate for that patient, within the licensed indication. For weight-loss injections that means adults with a BMI of 30 or above, or 27 or above with a relevant weight-related condition, though BMI alone never settles the matter. The prescriber assesses the full clinical picture. Some patients find private access useful around NHS waiting lists; others simply prefer the speed and continuity of a dedicated service. If you are weighing up the options, our guide to how to buy weight loss injections through a regulated service explains the steps involved. Ordering before 12pm on a weekday tends to suit people who want treatment to arrive before the weekend (or even just before a busy stretch at work) and a next-working-day DPD delivery makes that predictable.

For a broader look at how weight-loss injection treatment works from start to finish, that page walks through the process in plain terms.

What are the signs that a seller is not operating within the regulatory framework?

This is worth being direct about. Unregistered sellers exist, and their products carry real risk. The main signals to watch for:

A legitimate pharmacy will always appear on the GPhC register, full stop. If you cannot find it there, do not proceed. Sellers operating without a prescription, whether through a checkbox questionnaire with no clinical review or through no assessment at all, are outside the law. Prices that sit dramatically below market rates often signal counterfeit stock; the licensed supply chain has costs that cannot be wished away. Discount codes and promotional offers attached to Prescription-Only Medicines are themselves a regulatory red flag, since advertising POMs to the public is prohibited.

If you are already on treatment and considering transferring to a new provider, a regulated service will ask for evidence of your current dose and recent weight before continuing, that is a protection, not bureaucracy. It is also worth understanding how weight loss medication injections are assessed and dispensed differently depending on the provider you choose. The FAQs page covers common questions about transfers and what to expect.

If you want to check your eligibility for treatment through a clinician-led, GPhC-registered service, people often find it helpful to read about the three main weight loss injections available before deciding which consultation to start. You can also explore information on weight loss injection r if you are looking into all the options currently on the market. Starting your free consultation is straightforward.